MIR205HG

Mutation & survival
SurvivalMutationKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, MIR205HG Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MIR205HG data layer compared with 19 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher MIR205HG Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR205HG expression acts as an unfavorable survival marker.

SKCM are the cancer types where MIR205HG Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
SKCMDFSMedianAll0.2160.616.0013view →
Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

MIR205HG–SKCM (DFS)

Kaplan–Meier survival curve for MIR205HG mutant vs wild-type samples in SKCM.

Open the SKCM breakdown →

Exploration